|Bid||76.51 x 800|
|Ask||76.98 x 800|
|Day's range||75.32 - 76.14|
|52-week range||26.49 - 81.80|
|Beta (5Y monthly)||1.27|
|PE ratio (TTM)||17.98|
|Earnings date||27 Jan 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||87.69|
Strength in Molecular Diagnostics business is likely to have continued to aid Hologic's (HOLX) performance in the first quarter of fiscal 2021 amid the coronavirus-led economic doldrums.
Top Ranked Growth Stocks to Buy for January 21st
Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.